Last: | $ |
---|---|
Change Percent: | -6.76% |
Open: | $0.22 |
Close: | $0.207 |
High: | $0.2359 |
Low: | $0.203 |
Volume: | 1,010,503 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$ | $0.22 | $0.207 | $0.2359 | $0.203 | 1,010,503 | 03-04-2019 |
$ | $0.26 | $0.222 | $0.278 | $0.22 | 2,155,492 | 03-01-2019 |
$ | $0.27 | $0.275 | $0.2997 | $0.262 | 2,469,167 | 02-28-2019 |
$ | $0.282 | $0.3095 | $0.36 | $0.28 | 5,258,654 | 02-27-2019 |
$ | $0.321 | $0.295 | $0.33 | $0.2915 | 1,267,041 | 02-26-2019 |
$ | $0.3124 | $0.32 | $0.3701 | $0.30 | 2,614,724 | 02-25-2019 |
$ | $0.41 | $0.32 | $0.42 | $0.31 | 5,730,789 | 02-22-2019 |
$ | $0.271 | $0.39 | $0.4401 | $0.26 | 16,341,966 | 02-21-2019 |
$ | $0.31 | $0.291 | $0.3498 | $0.255 | 6,006,846 | 02-20-2019 |
$ | $0.45 | $0.3615 | $0.6684 | $0.34 | 12,089,153 | 02-19-2019 |
$ | $1.60 | $1.14 | $1.60 | $1.13 | 2,174,092 | 02-18-2019 |
$ | $1.60 | $1.14 | $1.60 | $1.13 | 2,174,092 | 02-15-2019 |
$ | $1.58 | $1.61 | $1.78 | $1.52 | 1,427,152 | 02-14-2019 |
$ | $1.24 | $1.82 | $2.20 | $1.13 | 14,465,996 | 02-13-2019 |
$ | $0.899 | $1.19 | $1.19 | $0.882 | 1,494,396 | 02-12-2019 |
$ | $0.90 | $0.871 | $0.90 | $0.85 | 258,280 | 02-11-2019 |
$ | $0.82 | $0.83 | $0.87 | $0.70 | 550,132 | 02-08-2019 |
$ | $0.86 | $0.82 | $0.9399 | $0.77 | 902,828 | 02-07-2019 |
$ | $0.76 | $0.8799 | $1.00 | $0.68 | 1,984,390 | 02-06-2019 |
$ | $0.5747 | $0.70 | $0.76 | $0.53 | 1,085,640 | 02-05-2019 |
News, Short Squeeze, Breakout and More Instantly...
Pernix Therapeutics Holdings Inc. Company Name:
PTX Stock Symbol:
NASDAQ Market:
Transaction that includes the sale of substantially all of Pernix’s assets to be valued at $75.6 million Pernix voluntarily files for Chapter 11 protection Pernix intends to continue to operate with no...
NEW YORK, NY / ACCESSWIRE / February 14, 2019 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive report on Pernix Therapeutics Holdings, Inc., (NASDAQ: PTX) Pernix is the parent com...